Literature DB >> 31837385

Primary ductal adenocarcinoma of the lacrimal gland: A review and report of five cases.

Thonnie Rose O See1, Gustav Stålhammar2, Tina Tang3, Joshua S Manusow3, David R Jordan3, Jeffrey A Nerad4, Robert C Kersten5, Marc Yonkers6, Nasreen A Syed7, Seymour Brownstein3, Hans E Grossniklaus8.   

Abstract

Primary ductal adenocarcinoma (PDA) is a rare epithelial tumor of the lacrimal gland. Herein we report 5 cases and review 29 published cases of PDA of the lacrimal gland. Among these 5 cases, the most common clinical presentation was painless swelling and/or proptosis of their eye. The size of the lesions ranged from 1.6 to 2.5 cm. Histopathologic examination revealed proliferations of ductal or gland-like cells with vesiculated pleomorphic nuclei and prominent nucleoli. Tumor cells stained positive for epithelial and apocrine differentiation markers. Immunohistochemistry for human epidermal growth factor 2 was positive in 2 of the 4 cases. Four of the five patients were alive at the last follow-up visit. One died with bone metastases, which were diagnosed 25 months after exenteration and then survived an additional 51 months. On reviewing of twenty-nine previously published cases of PDA, the mean age of diagnosis was 58 years, with a male predominance (75%). Fifteen patients (54%) had distant metastases, 1 (4%) had local recurrence, and 10 (37%) suffered from a PDA-related death. PDA is a high-grade aggressive epithelial tumor of the lacrimal gland. Although rare, awareness and recognition of this malignancy are important to help determine prognosis and treatment options.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  immunohistochemistry; lacrimal gland; metastases; primary ductal adenocarcinoma

Mesh:

Substances:

Year:  2019        PMID: 31837385      PMCID: PMC7215120          DOI: 10.1016/j.survophthal.2019.11.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  24 in total

1.  Primary ductal adenocarcinoma of the lacrimal gland.

Authors:  Yoon Jung Lee; Young-Ha Oh
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

2.  Epithelial tumors of the lacrimal glands: a clinicopathologic study.

Authors:  A F Paulino; A G Huvos
Journal:  Ann Diagn Pathol       Date:  1999-08       Impact factor: 2.090

3.  Primary ductal adenocarcinoma of the lacrimal gland.

Authors:  Tatyana Milman; Jerry A Shields; Michael Husson; Brian P Marr; Carol L Shields; Ralph C Eagle
Journal:  Ophthalmology       Date:  2005-11       Impact factor: 12.079

4.  Primary ductal adenocarcinoma of the lacrimal gland: case report.

Authors:  Renato Wendell Ferreira Damasceno; Leonard M Holbach
Journal:  Arq Bras Oftalmol       Date:  2012 Jan-Feb       Impact factor: 0.872

5.  Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment.

Authors:  Simon Andreasen; Morten Grauslund; Steffen Heegaard
Journal:  Acta Ophthalmol       Date:  2016-11-03       Impact factor: 3.761

Review 6.  Primary ductal adenocarcinoma of the lacrimal sac: the first reported case.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hideaki Kohzaki; Masahiko Arikata; Takeshi Shimizu; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 7.  Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature.

Authors:  Toshinobu Kubota; Suzuko Moritani; Shu Ichihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-24       Impact factor: 3.117

8.  Cystic carcinoma ex pleomorphic adenoma of the lacrimal gland.

Authors:  Masayuki Takahira; Hiroshi Minato; Mami Takahashi; Kousei Karino; Kazuhisa Sugiyama
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Sep-Oct       Impact factor: 1.746

9.  A benign presentation of primary ductal adenocarcinoma of lacrimal gland: A rare malignancy.

Authors:  Lindfay Laura Lau; Chong Ka Lung; Syed Shoeb Ahmad
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

10.  Metastatic, her-2 amplified lacrimal gland carcinoma with response to lapatinib treatment.

Authors:  Trevor Dennie
Journal:  Case Rep Oncol Med       Date:  2015-02-02
View more
  2 in total

1.  Clinico-epidemiological analysis of 1000 cases of orbital tumors.

Authors:  Hiroshi Goto; Naoyuki Yamakawa; Hiroyuki Komatsu; Masaki Asakage; Kinya Tsubota; Shun-Ichiro Ueda; Rei Nemoto; Kazuhiko Umazume; Yoshihiko Usui; Hideki Mori
Journal:  Jpn J Ophthalmol       Date:  2021-07-27       Impact factor: 2.447

Review 2.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.